Company / Working Capital
Elanco Working Capital History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$1.9B
FY2025
5-year range
$1.6B / $2.2B
FY2021-FY2025
Trend
-2.1%
vs FY2024
Sector context
#22 of 213
Health Care
What the data says
Among 213 Health Care companies, Elanco is in the top 10% for working capital. Working Capital has fluctuated over the past 9 years, ranging from $1.3B in FY2020 to $2.2B in FY2023.
Based on SEC 10-K filings.
$1.9B in FY2025 with a 5-year CAGR of +6.8%. Top quartile in the Health Care sector.
Declined from $2.2B to $1.9B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +5.7%
- 5-Year CAGR
- +6.8%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 213This company $1.9B Sector average $934.6M
▼
+99.1% above sector average
Key checks
Key Insights
- 5-year CAGR of +6.8%, indicating consistent growth.
- In FY2025, working capital decreased 2.1% year-over-year.
- Ranks #22 out of 213 companies in the Health Care sector.
- Peak working capital was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.9B | -2.1% |
| FY2024 | $1.9B | -12.3% |
| FY2023 | $2.2B | +37.3% |
| FY2022 | $1.6B | -3.1% |
| FY2021 | $1.6B | +21.4% |
| FY2020 | $1.3B | -13.8% |
| FY2019 | $1.6B | +1.3% |
| FY2018 | $1.5B | +3.6% |
| FY2017 | $1.5B | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026